BioInvent International
Develops novel, first-in-class immuno-modulatory antibodies for cancer therapy.
BINV | ST
Overview
Corporate Details
- ISIN(s):
- SE0015244520
- LEI:
- 549300E7QRHEF2IJUY10
- Country:
- Sweden
- Address:
- C/O BioInvent International Aktiebolag, 223 70 Lund
- Website:
- https://www.bioinvent.com/en
- Sector:
- Manufacturing
Description
BioInvent International is a clinical-stage company that discovers and develops novel, first-in-class immuno-modulatory antibodies for cancer therapy. Leveraging extensive expertise in immunology, cancer biology, and antibody biology, the company generates innovative immuno-oncology drug candidates for its clinical pipeline. BioInvent's operations include an in-house manufacturing facility to produce antibodies for its preclinical studies and clinical trials, with the goal of developing treatments that can transform the lives of cancer patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2016-02-16 20:45 |
BioInvent issues private placement to US-based healthcare investor Omega Funds …
|
English | 84.7 KB | ||
| 2016-02-16 20:45 |
BioInvent genomför riktad emission till den USA-baserade health care-investerar…
|
Swedish | 73.3 KB | ||
| 2016-01-07 12:30 |
BioInvent meddelar att FDA har godkänt IND-ansökan för fas I/IIa-studien med TB…
|
Swedish | 46.6 KB | ||
| 2016-01-07 12:30 |
BioInvent announces FDA acceptance of the Investigational New Drug application …
|
English | 56.5 KB | ||
| 2015-12-17 08:40 |
BioInvent utsett av globalt läkemedelsbolag till leverantör av produktionstjäns…
|
Swedish | 44.9 KB | ||
| 2015-12-17 08:40 |
BioInvent selected for manufacturing services by global pharmaceutical company;…
|
English | 45.0 KB | ||
| 2015-12-16 08:40 |
BioInvent lämnar uppdatering om bolagets kliniska och prekliniska läkemedelspro…
|
Swedish | 66.2 KB | ||
| 2015-12-16 08:40 |
BioInvent update on clinical and preclinical drug programs
|
English | 92.2 KB | ||
| 2015-12-10 08:40 |
BioInvent inlicensierar banbrytande teknologi för utveckling av mer effektiva c…
|
Swedish | 58.6 KB | ||
| 2015-12-10 08:40 |
BioInvent in-licenses cutting edge technology to pave the way for more efficaci…
|
English | 67.6 KB | ||
| 2015-10-22 08:40 | Swedish | 217.8 KB | |||
| 2015-10-22 08:40 | English | 191.8 KB | |||
| 2015-09-28 08:40 |
BioInvent deltar i Ladenburg Thalmann 2015 Healthcare Conference
|
Swedish | 43.4 KB | ||
| 2015-09-28 08:40 |
BioInvent to Participate in Ladenburg Thalmann 2015 Healthcare Conference
|
English | 43.4 KB | ||
| 2015-09-21 08:40 |
BioInvent and the University of Pennsylvania enhance planned clinical study wit…
|
English | 50.4 KB |
Automate Your Workflow. Get a real-time feed of all BioInvent International filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BioInvent International
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BioInvent International via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-01-09 | Erik Esveld | Other | Buy | 4,000 | 70,960.00 SEK |
| 2023-06-30 | Sylvie Ryckebusch | Other | Buy | 5,000 | 7,890.00 EUR |
| 2022-11-16 | Dharminder Chahal | Other | Buy | 10,000 | 352,500.00 SEK |
| 2022-03-09 | Martin Welschof | Other | Buy | 3,262 | 109,798.92 SEK |
| 2022-03-09 | Martin Welschof | Other | Buy | 800 | 27,200.00 SEK |
| 2022-03-09 | Martin Welschof | Other | Buy | 750 | 25,425.00 SEK |
| 2022-03-09 | Martin Welschof | Other | Buy | 611 | 20,700.68 SEK |
| 2022-03-09 | Martin Welschof | Other | Buy | 530 | 17,193.20 SEK |
| 2022-03-09 | Martin Welschof | Other | Buy | 500 | 16,800.00 SEK |
| 2022-03-09 | Martin Welschof | Other | Buy | 400 | 13,712.00 SEK |
Peer Companies
